SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,594,901 | +803.2% | 71,623 | +789.3% | 0.02% | +700.0% |
| Q4 2022 | $287,286 | -72.4% | 8,054 | -73.8% | 0.00% | -66.7% |
| Q3 2022 | $1,040,000 | +82.1% | 30,735 | +74.0% | 0.01% | +20.0% |
| Q1 2022 | $571,000 | -74.0% | 17,667 | -76.5% | 0.01% | -76.2% |
| Q4 2021 | $2,196,000 | +826.6% | 75,303 | +879.0% | 0.02% | +600.0% |
| Q2 2021 | $237,000 | -80.1% | 7,692 | -83.7% | 0.00% | -81.2% |
| Q4 2020 | $1,190,000 | -19.3% | 47,280 | -23.9% | 0.02% | -36.0% |
| Q2 2020 | $1,475,000 | +201.0% | 62,091 | +128.0% | 0.02% | +92.3% |
| Q1 2020 | $490,000 | -18.9% | 27,232 | +6.9% | 0.01% | +18.2% |
| Q4 2019 | $604,000 | +81.9% | 25,481 | +111.0% | 0.01% | +57.1% |
| Q3 2019 | $332,000 | -71.0% | 12,079 | -65.1% | 0.01% | -66.7% |
| Q2 2019 | $1,146,000 | +13.9% | 34,624 | +20.6% | 0.02% | -36.4% |
| Q1 2019 | $1,006,000 | +61.0% | 28,699 | +52.5% | 0.03% | +10.0% |
| Q4 2018 | $625,000 | +29.1% | 18,817 | +95.6% | 0.03% | +15.4% |
| Q3 2018 | $484,000 | +138.4% | 9,622 | +183.0% | 0.03% | +160.0% |
| Q2 2018 | $203,000 | -30.7% | 3,400 | -53.8% | 0.01% | -37.5% |
| Q4 2017 | $293,000 | +306.9% | 7,356 | +156.2% | 0.02% | +166.7% |
| Q4 2016 | $72,000 | -81.7% | 2,871 | -81.9% | 0.01% | -76.0% |
| Q3 2016 | $393,000 | +54.7% | 15,899 | +27.4% | 0.02% | +66.7% |
| Q2 2016 | $254,000 | +71.6% | 12,480 | +28.4% | 0.02% | +87.5% |
| Q1 2016 | $148,000 | -20.0% | 9,719 | -29.3% | 0.01% | -27.3% |
| Q4 2015 | $185,000 | -54.3% | 13,753 | -52.4% | 0.01% | -45.0% |
| Q3 2015 | $405,000 | -41.0% | 28,865 | -28.7% | 0.02% | -41.2% |
| Q2 2015 | $687,000 | +408.9% | 40,467 | +149.0% | 0.03% | +385.7% |
| Q4 2014 | $135,000 | -32.2% | 16,252 | -28.9% | 0.01% | -41.7% |
| Q3 2014 | $199,000 | – | 22,855 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |